Scaffolding strategies for tissue engineering and regenerative medicine applications

S Pina, VP Ribeiro, CF Marques, FR Maia, TH Silva… - Materials, 2019 - mdpi.com
During the past two decades, tissue engineering and the regenerative medicine field have
invested in the regeneration and reconstruction of pathologically altered tissues, such as …

3D bioprinting: current status and trends—a guide to the literature and industrial practice

S Santoni, SG Gugliandolo, M Sponchioni… - Bio-Design and …, 2022 - Springer
The multidisciplinary research field of bioprinting combines additive manufacturing, biology
and material sciences to create bioconstructs with three-dimensional architectures …

Personalised organs-on-chips: functional testing for precision medicine

A Van Den Berg, CL Mummery, R Passier… - Lab on a Chip, 2019 - pubs.rsc.org
Organs-on-chips are microfluidic systems with controlled, dynamic microenvironments in
which cultured cells exhibit functions that emulate organ-level physiology. They can in …

Stem cell therapy in heart diseases–cell types, mechanisms and improvement strategies

P Müller, H Lemcke, R David - Cellular Physiology and Biochemistry, 2018 - karger.com
A large number of clinical trials have shown stem cell therapy to be a promising therapeutic
approach for the treatment of cardiovascular diseases. Since the first transplantation into …

Drug compound screening in single and integrated multi-organoid body-on-a-chip systems

A Skardal, J Aleman, S Forsythe, S Rajan… - …, 2020 - iopscience.iop.org
Current practices in drug development have led to therapeutic compounds being approved
for widespread use in humans, only to be later withdrawn due to unanticipated toxicity …

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy

M Chehelgerdi, F Behdarvand Dehkordi… - Molecular Cancer, 2023 - Springer
The advent of iPSCs has brought about a significant transformation in stem cell research,
opening up promising avenues for advancing cancer treatment. The formation of cancer is a …

Pharmaceutical applications of 3D printing

G Chen, Y Xu, PCL Kwok, L Kang - Additive Manufacturing, 2020 - Elsevier
Abstract Although 3D printing (3DP) has long been an integral part of industries such as
aviation and automotive, its use in healthcare, especially the pharmaceutical industry, is …

Immersion bioprinting of tumor organoids in multi-well plates for increasing chemotherapy screening throughput

E Maloney, C Clark, H Sivakumar, KM Yoo, J Aleman… - Micromachines, 2020 - mdpi.com
The current drug development pipeline takes approximately fifteen years and $2.6 billion to
get a new drug to market. Typically, drugs are tested on two-dimensional (2D) cell cultures …

Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform

SAP Rajan, J Aleman, MM Wan, NP Zarandi, G Nzou… - Acta biomaterialia, 2020 - Elsevier
Current drug development techniques are expensive and inefficient, partially due to the use
of preclinical models that do not accurately recapitulate in vivo drug efficacy and cytotoxicity …

3D bioprinting for high-throughput screening: Drug screening, disease modeling, and precision medicine applications

A Mazzocchi, S Soker, A Skardal - Applied Physics Reviews, 2019 - pubs.aip.org
High-throughput technologies have become essential in many fields of pharmaceutical and
biological development and production. Such technologies were initially developed with …